DEXCOM INC·4

Feb 2, 4:46 PM ET

Brown Michael Jon 4

Research Summary

AI-generated summary

Updated

Dexcom (DXCM) EVP Michael Brown Receives 7,123 Shares

What Happened Michael Jon Brown, EVP and Chief Legal Officer of Dexcom (DXCM), received 7,123 shares on January 29, 2026 as the result of performance-based restricted stock units (PSUs) vesting (transaction code A). To satisfy tax withholding on the net settlement, 2,653 shares were withheld by the company at an effective price of $73.36 per share, valued at $194,624 (transaction code F). The withholding is a remittance to cover taxes and is not a market sale by Brown.

Key Details

  • Transaction date: January 29, 2026. Filing date: February 2, 2026 (timely).
  • Award: 7,123 shares issued at $0.00 (PSU vesting).
  • Tax withholding: 2,653 shares withheld at $73.36 = $194,624 remitted for taxes (not a sale).
  • Footnotes: F1 confirms shares resulted from PSU vesting (grant date Mar 8, 2023). F2 clarifies the withheld shares were for tax remittance and not a sale. F3 lists 86,490 unvested RSUs still held (various grant dates/vesting schedules) plus 83 ESPP shares included in reported holdings.
  • Filing shows no 10b5-1 instruction and no indication of a late filing.

Context This was an equity award payout (PSU vesting) with company withholding to cover tax obligations — a routine administrative transaction rather than an open-market sale or purchase. For retail investors, awards and withholding typically reflect compensation mechanics and do not by themselves signal insider buying or selling intent.